Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. Government revenue collected in recreational marijuana excise taxes totaled $31 million in fiscal year 2020.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

Project CBD

MARCH 21, 2023

I nterestingly, and perhaps unfortunately for patients, previous reviews in 2020 and 2019 2 also concluded there was insufficient evidence that cannabis can diminish chronic tinnitus. Cannabinoid Receptors Influence Hearing Finally, a November 2020 review in Frontiers in Neurology 6 adds more complexity and subtlety to the issue.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 40

Clinical Trials Data Patients THC 40

Cannabis Law Report

DECEMBER 9, 2021

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. Advancements in IP and Drug Development.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

AUGUST 12, 2021

loss per share, during the same period in 2020 (after including non-cash share-based compensation expense of $11.4 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs. SOURCE InMed Pharmaceuticals Inc.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. from 2020 to 2030 and generate revenue of $151.7 The global chronic pain treatment market is predicted to progress at a CAGR of 6.5%

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. This was somewhat less than the nearly 37% decline seen in 2020.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JULY 8, 2021

The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids.

Research and Development 85

Research and Development Pets Cannabinoids eCommerce 85

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 122

Research and Development Data THC Clinical Trials 122

Cannabis Law Report

MARCH 22, 2020

A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza. 9:46 AM – Mar 19, 2020.

THC 59

THC Clinical Trials Data Consumption 59

Cannabis Law Report

MAY 10, 2022

Data obtained through a freedom of information request to drugs regulator the Therapeutic Goods Administration (TGA) revealed the age of those prescribed the drugs, the reason for prescribing, and the state or territory where the prescription was made. We are aware of clinical trials in that space, but not strong evidence.”.

Medicine 52

Medicine Clinical Trials Data Sleep 52

LifeCannMD

MAY 27, 2025

Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. After six months of microdosing marijuana (2mg THC + 2mg CBD twice daily), his pain went from an 8/10 to a 3/10, and he’s back to playing golf three times a week.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. The authors note, however, that the data doesn’t include patient outcomes. Here’s the Uni of Sydney press release. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Key Priorities for 2020.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Law Report

JANUARY 10, 2022

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. In 2020, based on application, the others segment accounted for the largest revenue share. List To Data Sources.

Cannabinoids 40

Cannabinoids Clinical Trials Research and Development Supply Chain 40

Cannabis Law Report

NOVEMBER 12, 2021

Completed manufacturing of ANEB-001 capsules for upcoming Phase 2 clinical trial. On track to commence Phase 2 proof-of-concept clinical trial with ANEB-001 for the treatment of acute cannabinoid intoxication by year-end. Condensed Balance Sheet Data. . . The founding co-chairs are Andrew Monte, M.D., 241,633.

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “We

Clinical Trials 40

Clinical Trials Research and Development Data Patients 40

Cannabis Law Report

MARCH 29, 2020

o Technology powered research: Virtual clinical trials and other accelerated technologies that mix the potential of new technologies with cannabis to create research insights quickly and more accurately, are being classified as Cannabis 3.0, triggering new innovations and improved data quality through better user experiences.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

DECEMBER 21, 2021

Also in November, it reported positive data on its standout IND, CYB003. Within a few months, it had completed the first phase of its clinical trial of DMT in combination with supportive psychotherapy and commenced a phase 2a trial. Tryp Therapeutics began trading on the CSE in December 2020.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

NOVEMBER 26, 2021

Can-Fite Ends Phase II COVID-19 Trial to Focus on Core Indications – In 2020, with the aim of developing a much-needed drug to treat manifestations of COVID-19, mainly the Cytokine Release Syndrome, Can-Fite initiated a Phase II COVID-19 study of its lead drug candidate, Piclidenoson, with patient enrollment in Israel and Europe.

Clinical Trials 40

Clinical Trials Research and Development Treatment Data 40

Cannabis Law Report

MAY 29, 2022

The company has been building its two adjacent 10,000 square foot facilities since August 2020. And there are literally hundreds of trials that are being done, and more forthcoming.”. The psilocybin mushrooms are headed to clinical trials, drug companies and medical facilities. “I’m

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

AUGUST 3, 2021

FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. Food and Drug Administration (U.S.

Clinical Trials 81

Clinical Trials Therapy Collective Research and Development 81

Cannabis Law Report

SEPTEMBER 2, 2021

FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. Food and Drug Administration (U.S.

Clinical Trials 76

Clinical Trials Research and Development Therapy Collective 76

Cannabis Law Report

JUNE 7, 2021

1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. Department of Agriculture (USDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final or conditional approval from the U.S.

Clinical Trials 49

Clinical Trials Research and Development Therapy Supply Chain 49

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Puff Puff Post

JANUARY 1, 2020

National legalisation of medical cannabis could occur as early as 2020 in Spain. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain. Vice President of Spain Pablo Iglesias is a huge proponent of complete legalisation. Spain researches advanced use of cannabis medications.

Treatment 49

Treatment Clinical Trials Research and Development Cannabinoids 49

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 40

Clinical Trials Research and Development Data Business 40

Cannabis Law Report

OCTOBER 12, 2021

SAN DIEGO–(BUSINESS WIRE)– #CBD — Radicle Science , a transformative healthtech B-corp validating consumer health products for the first time, secured its initial seed funding in Q4 2020 and surpassed numerous major milestones with accelerating momentum in the first three quarters of 2021. Notably, Peter H.

Clinical Trials 40

Clinical Trials Research and Development Sleep Cannabinoids 40

The Joint Blog

FEBRUARY 24, 2021

The effects were so promising that Parkinson’s UK began funding for the worlds first clinical trial. This trial would be used to assess whether or not CBD could treat the psychosis symptoms of Parkinson’s. This trial was to take 3.5 However, they also stated that there have been promising effects noted in lab studies.

Treatment 55

Treatment Clinical Trials Collective Patients 55

Canna Care Docs

DECEMBER 16, 2020

Between the pandemic and the political climate, 2020 hasn’t exactly been a walk in the park. Although the data is still growing, small studies and anecdotal evidence seem promising for medical marijuana as treatment for psychiatric disorders like depression, anxiety and PTSD. Chronic pain.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

DECEMBER 7, 2021

The search included studies through 11-May-2020. However, despite the increased use of MCs in children, there is limited data regarding their safety and efficacy in this population for those different indications 11. The search included published and unpublished studies through 11-May-2020.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

DECEMBER 17, 2021

In 2020, the total prevalent cases of 22q11.2 deletion syndrome cases in the 7MM, accounting for approximately 42% of the total 7MM cases in 2020. deletion syndrome were in Germany and the least in Spain in 2020. deletion syndrome were in Germany and the least in Spain in 2020. deletion syndrome were 35,203 in 2020.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Therapy 40

Cannabis Law Report

OCTOBER 26, 2021

MyMD plans to advance MYMD-1 in the clinic with two simultaneous Phase 2 trials beginning in the current quarter, one for delaying aging and prolonging healthy lifespan, and the second for COVID-19-associated depression and cytokine elevation. 1 Data published by Research and Markets, March 2018. Dr. Chapman Bio. 646) 421-9523.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Puff Puff Post

JANUARY 1, 2020

National legalisation of medical cannabis could occur as early as 2020 in Spain. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain. Vice President of Spain Pablo Iglesias is a huge proponent of complete legalisation. Spain researches advanced use of cannabis medications.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

NOVEMBER 15, 2021

The Company is developing this product candidate as a prophylactic treatment against SARS and influenza and has engaged Syneos Health to assist with the optimal clinical trial design. FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020. Three Months Ended September 30, 2021 and 2020.

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

NOVEMBER 15, 2021

Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law.

Research and Development 40

Research and Development Therapy Clinical Trials Supply Chain 40